Psychotic symptoms during or after stimulant use need prompt clinical assessment. Hearing or seeing things others do not, strongly believing that others are plotting harm, or having difficulty distinguishing what is real can be frightening and can affect safety. Do not wait to prove that a stimulant caused the symptoms before seeking help. If there is immediate danger, severe agitation, confusion, a medical emergency, or inability to stay safe, contact emergency services.
The urgent question is what care the person needs now. The longer-term question is how the episode relates to stimulant use, sleep, medications, other substances, and possible mental or physical illness. These questions should be connected but not confused. A final diagnosis may require follow-up, while immediate assessment and treatment should not be postponed until every uncertainty is resolved.
Understand psychosis as a description, not a complete explanation
NIMH describes psychosis as a collection of symptoms involving some loss of contact with reality. It can occur in several circumstances and does not automatically mean schizophrenia. Mental health conditions, sleep deprivation, certain medicines, and substance use can all be relevant to assessment. A person can experience psychosis without ultimately receiving a particular long-term diagnosis.
Describe the experience in concrete terms. What did the person hear, see, believe, or do? When did it begin, and what changed from their usual behavior? Clinicians need this information alongside current safety and physical symptoms. A label such as paranoia may be less informative than an account of the actual fear and how it is affecting actions.
Avoid assuming that apparently plausible concerns rule out a serious problem, or that unusual beliefs make every other concern invalid. The clinician needs to assess the whole situation. If there are physical symptoms after stimulant use, those also require attention. The assessment should not become exclusively psychiatric simply because the person is frightened or behaving unusually.
Give the assessing team a complete substance history
Include cocaine, methamphetamine, prescribed stimulants, and any other relevant products. Explain recent frequency, changes in use, the last known use, and periods of prolonged wakefulness. Add alcohol, cannabis, sedatives, opioids, and other medicines. If product contents or amounts are uncertain, say so rather than presenting a guess as confirmed information.
If a prescribed stimulant is involved, describe whether it was taken as directed, missed, increased, or obtained from someone else. A prescription and an illicit product are not identical histories, but both can be relevant to assessment. Do not stop or change established treatment independently while waiting for routine advice; serious new symptoms need prompt clinical review and a clear plan from the responsible clinician.
The SAMHSA stimulant treatment guide discusses stimulant-induced psychosis and the need to consider other explanations and appropriate care settings. Our symptom timeline guide can help organize the sequence once the immediate situation is safe. It is a tool for the clinical discussion, not a way to diagnose the episode at home.
The timing matters, but it does not settle causation
Symptoms appearing after stimulant use may support a substance-related explanation, but clinicians also ask about earlier episodes, symptoms outside periods of use, family history, other illnesses, and medication changes. Different factors can coexist. Stimulant use may complicate an existing condition, and an apparent substance-related episode may still require further psychiatric follow-up.
SAMHSA notes that distinguishing acute from persistent stimulant-related psychosis can require repeated assessment. Do not use a short expected timeline to decide that symptoms are harmless or that continuing symptoms prove one particular diagnosis. The appropriate interpretation depends on the full course and assessment, not only the date of the last reported dose.
Ask what the working explanation is and what evidence might change it. A clinician should be able to identify uncertainty while still explaining the current treatment needs. Our guide to co-occurring and substance-induced conditions explains why a provisional diagnosis can be useful when it comes with a clear review process.
Choose a setting capable of managing the current symptoms
Ask whether the person needs an emergency department, acute psychiatric assessment, hospital care, or another service. The answer depends on medical and psychiatric needs, safety, and available support. A residential addiction program should not be assumed suitable solely because it advertises dual diagnosis or offers a quiet environment.
Clarify who can assess new symptoms, who prescribes, and what happens outside normal hours. A weekly visiting psychiatrist is a different arrangement from immediate psychiatric support. The proposed service should explain its capabilities and limits in relation to the actual presentation. If it recommends a higher level of care, ask how the referral and handoff will be arranged.
Do not travel a long distance to a preferred program in place of local urgent assessment. If a transfer is appropriate after stabilization, both teams should agree that the receiving service can meet the person’s needs. The patient and supporters should know who is responsible during the interval rather than relying on an admissions reservation as a care plan.
Supporters can reduce conflict without endorsing a belief
Speak calmly and use simple language. Acknowledge that the experience is frightening without arguing over every detail or agreeing that an unverified threat is real. Ask what would help the person accept professional assessment. A crowded confrontation or repeated demands to admit that a belief is false may make communication more difficult.
Keep your own safety in view. Do not attempt to physically restrain someone or manage escalating danger alone. Tell emergency services about immediate risks and follow their instructions. If there is no immediate danger but symptoms are new or worsening, seek urgent professional advice. Supportive conversation is useful, but it does not replace assessment.
With appropriate consent when possible, provide observations to the care team. You might know about a change in sleep, medication, or substance use that the person cannot recall clearly. State what you observed and avoid speculation about motives. The clinician can explain how information from supporters is incorporated while respecting the patient’s participation and privacy.
Treatment should address symptoms and substance use together
Ask how the team will manage the current psychotic symptoms and what treatment is proposed for stimulant use. Medication may be part of clinical care, but the choice, monitoring, and duration belong to the treating clinician. Do not use leftover prescriptions, borrowed sedatives, or alcohol to settle symptoms. The team needs to know what has actually been taken.
NIMH describes treatment for psychosis as potentially including medication, psychotherapy, family education, and support with daily life. Coordinated specialty care is one approach used for early psychosis. Ask whether an appropriate service is available and how substance use care will connect with it. A referral should identify a next contact rather than leave the person to search alone after an acute episode.
If symptoms improve, continue the agreed follow-up. Improvement does not by itself determine how long medication should continue or whether the diagnosis is settled. Ask the clinician how decisions will be reviewed and what signs should prompt earlier contact. Abruptly ending care because the immediate fear has passed can leave important questions unanswered.
Rebuild the daily plan around actual needs
Discuss sleep, housing, work or study, relationships, and access to substances with the team. These practical circumstances can affect whether the treatment plan is usable. A person returning to an unstable environment may need different support from someone with reliable housing and an established clinical team. Avoid assuming that discharge instructions alone solve those barriers.
Ask which activities should wait until further review and what support is needed to resume them. Driving, safety-sensitive work, and international travel require particular attention when judgment, concentration, or medication effects are a concern. The decision should be individualized. Do not infer readiness from appearing calmer during one conversation.
Supporters may help with transport, appointments, or a limited daily task if the person agrees. They should not become the sole monitoring service or be expected to decide whether every belief or symptom is clinically significant. A professional contact route and clear review arrangements remain necessary even when family support is strong.
Ask the clinician to describe the person’s usual baseline and which changes supporters should report. This can help distinguish a new concern from longstanding habits without turning relatives into diagnosticians. Agree how the patient wants concerns raised, who receives them, and how the team responds. Clear communication is especially useful when the person remembers the acute episode differently from those who witnessed it.
Leave the acute episode with a follow-up pathway
Before discharge or transfer, ask for the working diagnosis, current medicines, unresolved issues, and the next appointment in writing. Confirm which service has accepted responsibility and how urgent concerns should be raised. If records need to move between teams, ask whether they have been received. Sending a referral and completing a handoff are different steps.
NIMH’s co-occurring disorders guidance supports considering mental health and substance use together. For psychosis and stimulant use, that means treating the current problem, investigating the relationship over time, and keeping both parts of care connected. The person should leave with an understandable plan for what happens next, even when the final explanation of the episode remains under review.
Sources and further reading
Found a detail that has changed? Tell the editorial team.